References

Coxib and traditional NSAID Trialists' (CNT) Collaboration, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England). 2013; 382: 769–779. https://doi.org/10.1016/S0140-6736(13)60900-9

da Silva Filho AL, Caetano C, Lahav A, Grandi G, Lamaita RM. The difficult journey to treatment for women suffering from heavy menstrual bleeding: a multi-national survey. The European Journal of Contraception & Reproductive Health Care: the Official Journal of the European Society of Contraception. 2021; 26: 390–398. https://doi.org/10.1080/13625187.2021.1925881

Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, et al. Tranexamic Acid in Patients Undergoing Noncardiac Surgery. The New England Journal of Medicine. 2022; 386: 1986–1997. https://doi.org/10.1056/NEJMoa2201171

Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 2015; 128: 196–200. https://doi.org/10.1016/j.ijgo.2014.09.027

FSRH. UK Medical Eligibility Criteria For Contraceptive Use. 2016. Available at: https://www.fsrh.org/Common/Uploaded%20files/documents/fsrh-ukmec-full-book-2019.pdf (Accessed: 10 October 2024).

Lethaby A, Duckitt K, Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. The Cochrane Database of Systematic Reviews. 2013; CD000400. https://doi.org/10.1002/14651858.CD000400.pub3

Liu G, Yan YP, Zheng XX, Xu YL, Lu J, Hui RT, et al. Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation. The American Journal of Cardiology. 2014; 114: 1523–1529. https://doi.org/10.1016/j.amjcard.2014.08.015

Lukes AS, Moore K, Edlund M. Tranexamic Acid Treatment for Heavy Menstrual Bleeding: A Randomized Controlled Trial. Obstetrics and Gynecology. 2011; 117: 176–177. https://doi.org/10.1097/AOG.0b013e3182041e28

Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 2018; 143: 393–408. https://doi.org/10.1002/ijgo.12666

Myles PS, Smith JA, Painter T. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. The New England Journal of Medicine. 2017; 376: 1893. https://doi.org/10.1056/NEJMc1703369

NICE. Heavy menstrual bleeding: assessment and management. 2018. Available at: www.nice.org.uk/ng88 (Accessed: 10 October 2024).

Percy L, Mansour D, Fraser I. Iron deficiency and iron deficiency anaemia in women. Best Practice & Research. Clinical Obstetrics & Gynaecology. 2017; 40: 55–67. https://doi.org/10.1016/j.bpobgyn.2016.09.007

Taeuber I, Weibel S, Herrmann E, Neef V, Schlesinger T, Kranke P, et al. Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Surgery. 2021; 156: e210884. https://doi.org/10.1001/jamasurg.2021.0884

Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ (Clinical Research Ed.). 2011; 342: c7086. https://doi.org/10.1136/bmj.c7086